NAD+ injections arent known to interact with GLP-1 receptor agonists, and some clinics offer them specifically for GLP-1-related fatigue
Statements Author contributions KU: Writing original draft, Writing review & editing
Data extraction Two designated authors (AM and SS) meticulously extracted pertinent data from the included studies, including authorship details, publication timeline, samples of the study, mean demographic parameters (e.g., age, sex, baseline weight, and baseline BMI), type of bariatric surgery, prevalent background diseases, type of the GLP-1RAs therapy, the time of the initiation of the medical treatment, laboratory indices, amount of weight-change, and a comprehensive array of outcome measures, such as nausea, vomiting, diarrhea, and serious adverse events
10.1002/adfm.201908865 44 Luis Garcia-GimenezJ.MarkovicJ.DasiF.QuevalG.SchnaubeltD.FoyerC
No, you can not switch to another GLP-1 medication faster